Ragnar Vutt

Business delegation accompanying the Swedish royal couple were shown the UT's influential teaching and research areas and health technology

On 4 May, a Swedish business delegation visited the Estonian Biobank and the Delta Centre of the University of Tartu. The meeting aimed to foster new business contacts in the field of health technology and to introduce the university's influential teaching and research areas. 

The business delegation included representatives from Swedish health technology companies such as AstraZeneca, Asker Healthcare Group and others. 

According to Mart Maasik, Head of Entrepreneurship of the University of Tartu, we can be proud of the university's great research potential. "Sweden's leaders in health technology have shown that global success is ensured by cross-disciplinary collaboration as well as collaboration between researchers and businesses. This visit is a good opportunity for our research-intensive companies to forge international business connections and create joint growth opportunities with the Swedes, with whom we share a similar business culture," said Maasik before the visit. 

The visit started with a one-hour tour of the biobank, which, with its rich dataset, offers new opportunities for companies to create healthcare services and products in the future. The business delegation then moved to the Delta Centre, where Estonian research-intensive companies were showcased, and the future of health technology was discussed. 

After a joint lunch, the business delegation joined King Carl XVI Gustaf of Sweden and the official delegation for a tour of the Delta Centre. 

The King and the accompanying delegations were shown 

The business delegation's visit ended with a concluding discussion between representatives of Enterprise Estonia and Business Sweden. 

The visit of the business delegation was part of the state visit of King Carl XVI Gustaf and Queen Silvia of Sweden hosted by President Alar Karis. 



Find more to read:

Better Medicine'i meeskond

University of Tartu to acquire a stake in Better Medicine OÜ, a company that uses AI to diagnose cancer

Jaapani Yamaguchi Ülikooli ja linna esindus Tartu Ülikoolis

Representatives of Yamaguchi University and Yamaguchi City, Japan, visited the University of Tartu

Vectiopepi meeskond

Vectiopep raises €450,000 to develop novel cancer treatment technology